Stock listing

Xencor, Inc.

Selected listing: XNCR · NASDAQ · USD · US

Xencor, Inc. (NASDAQ:XNCR), Health Technology. Latest release Sep 2, 2026: Xencor to Present at the 2026 Cantor Global Healthcare Conference.

XNCR:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:XNCR
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Xencor, Inc.

Xencor, Inc. is a public company traded on the American stock market under the ticker XNCR. Xencor focuses on developing innovative monoclonal antibody therapies for the treatment of various diseases.

Latest news from Xencor, Inc.

Xencor to Present at the 2026 Cantor Global Healthcare Conference

September 2, 2026

Xencor Reports Second Quarter 2026 Financial Results

August 5, 2026

Xencor to Receive $105 Million from Alexion to Resolve Ultomiris U.S. Royalty Matter

July 30, 2026

Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter

July 29, 2026

Xencor Announces Proffered Paper Oral Presentation at ESMO 2026 for Phase 1 Clinical Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma

July 17, 2026

All Xencor, Inc. news →

Events

Replays

Xencor, Inc. (XNCR) Q1 2026 Earnings Call
Tue, May 12, 2026 · 06:00 PM ET
Watch
Xencor, Inc. (XNCR) Q4 2023 Earnings Call
Tue, Feb 27, 2024 · 04:30 PM ET
Watch
Xencor, Inc. (XNCR) Q3 2023 Earnings Call
Tue, Nov 07, 2023 · 04:30 PM ET
Watch

Research Xencor, Inc.

Xencor, Inc. company profile

View the public company page for Xencor, Inc. on 6ix.

Xencor, Inc. news

Read company news and market updates connected to Xencor, Inc..

Xencor, Inc. investor events

Find investor webinars, events, and replay context for Xencor, Inc..